Complementary therapies in cancer patients: Prevalence and patients' motives

Wiener Klinische Wochenschrift

Volumn 115, Issue 19-20, 2003, Pages 705-709

  Spiegel, Wolfgang ^a   Zidek, Thomas ^b   Vutuc, Christian ^b,c   Maier, Manfred ^a   Isak, Karin ^c   Micksche, Michael ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Viennese Cancer League   (Austria)

Author keywords

Complementary therapies; General practice; Health care providers; Health care surveys; Neoplasm

Indexed keywords

VISCUM ALBUM EXTRACT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BIORESONANCE; CANCER; CHELATION THERAPY; CHI SQUARE DISTRIBUTION; CHINESE MEDICINE; DIET RESTRICTION; DIET THERAPY; FEMALE; GENERAL PRACTITIONER; HOMEOPATHY; HUMAN; KINESIOLOGY; MALE; MANTEL HAENSZEL TEST; OXYGEN THERAPY; PHYTOTHERAPY; QUESTIONNAIRE; STATISTICAL ANALYSIS; VISCUM ALBUM;

EID: 0345172379     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03040886     Document Type: Article

References (29)

1. Eisenberg D, David RB, Ettner SL, Appel S, Wilkey S, van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990-1997. JAMA 280: 1569-1575
2. Ernst E, Resch KL, Mills S, Hill R, Mitchell A, Willoughby M, White A (1995) Complementary medicine - a definition. Br J Gen Pract 45: 506
3. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309: 86-89
4. Van der Zouwe N, van Dam FS, Aaronson NK, Hanewald GJ (1994) Alternative treatments in cancer: extent and background of utilisation. Ned Tijdschr Geneeskd 138: 300-306
5. Risberg T, Lund E, Wist E, Dahl O, Sundstrøm S, Andersen OK, et al (1995) The use of non-proven therapy among patients treated in Norwegian Oncological departments. A crosssectional national multicentre study. Eur J Cancer 31A: 1785-1789
6. Grothey A, Duppe J, Hasenburg A, Voigtmann R (1998) Use of alternative medicine in oncology patients. Dtsch Med Wochenschr 123: 923-929
7. Samur M, Bozcuk HS, Kara A, Savas B (2001) Factors associated with utilization of nonproven cancer therapies in Turkey. A study of 135 patients from a single center. Support Care Cancer 9: 452-458
8. Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 83: 777-782
9. Visser G, Peters L (1990) Alternative medicine and general practitioners in the Netherlands: towards acceptance and integration. Fam Pract 7: 227-232
10. White A, Resch K, Ernst E (1997) Complementary medicine: use and attitudes among general practitioners. Fam Pract 14: 302-306
11. Pirotta MV, Cohen MM, Kotsirilos V, Farish SJ (2000) Complementary therapies: have they become accepted in general practice? MJA 172: 105-109
12. McWhinney IR (1997) Alternative or complementary medicine. In: McWhinney IR (ed) A textbook of family medicine, 2nd edn. Oxford University Press, New York Oxford, pp 401-410
13. Turnheim K (2002) Alternative and rational therapies: irreconcilable differences. Wien Klin Wochenschr 114: 958-962
14. Widder J (2003) Alternatives and complements to scientific therapy forms: a question of theoretical medicine. Wien Klin Wochenschr 115: 85-87
15. Ernst E (2002) "Alternative" medicine and science - like fire and water? Wien Klin Wochenschr 114: 655-656
16. Ernst E (2003) Alternative und naturwissenschaftliche Therapieformen: unvereinbare Gegensätze? Wien Klin Wochenschr 115: 83-84
17. Fereberger W, Samonigg H, Pfeiffer KP, Rainer F (1983) Naturheilmittel und Paramedizin in der Onkologie - Ergebnisse einer Umfrage. Wien Med Wochenschr 17: 443
18. Beaufort F, Drofenik M, Pleyer K (1988) Beurteilung von Medikamenten mit fraglicher Wirksamkeit und sogenannten Naturheilmitteln in der Onkologie durch den Patienten. Wien Med Wochenschr 4: 85-91
19. Sollner W, Zingg-Schir M, Rumpold G, Fritsch P (1997) Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 133: 316-321
20. Connert K (2002) Alternative und komplementäre Medizin. Der Salzburger Arzt 16: 22-23
21. Matthews DE, Farewell VT (1996) Using and understanding medical statistics, 3rd rev edn. Karger, Basel
22. Tough SC, Johnston DW, Verhoef MJ, Arthur K, Bryant H (2002) Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med 8: 54-56, 58-60, 62-64
23. Metz JM, Jones H, Devine P, Hahn S, Glatstein E (2001) Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer J 7: 149-154
24. Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. NZ Med J 116: U296
25. Boon H, Steward M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18: 2515-2521
26. Montbriant MJ (1993) Freedom of choice: an issue concerning alternate therapies chosen by patients with cancer. Oncol Nurse Forum 20: 1195-1201
27. Alferi SM, Antoni MH, Ironson G, Kilbourn KM, Carver CS (2001) Factors predicting the use of complementary therapies in a multi-ethnic sample of early-stage breast cancer patients. J Am Med Womens Assoc 56: 120-123
28. Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R, Morton G, Danjoux C (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161: 1521-1524
29. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/altemative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18: 2505-2514